Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3617 | 1239 | 37.4 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
478 | 3 | PHAGE DISPLAY//CELL FREE PROTEIN SYNTHESIS//ANTIBODY ENGINEERING | 23687 |
3617 | 2 | Q BETA REPLICASE//NICOTINE VACCINE//IMMUNOPHARMACOTHERAPY | 1239 |
17163 | 1 | Q BETA REPLICASE//RNA PHAGE//RNA BACTERIOPHAGES | 614 |
20120 | 1 | NICOTINE VACCINE//IMMUNOPHARMACOTHERAPY//COCAINE HYDROLASE | 475 |
31640 | 1 | ANGIOTENSIN II VACCINE//EA4222//KINOID | 150 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | Q BETA REPLICASE | authKW | 452993 | 2% | 74% | 25 |
2 | NICOTINE VACCINE | authKW | 277647 | 1% | 87% | 13 |
3 | IMMUNOPHARMACOTHERAPY | authKW | 248487 | 1% | 92% | 11 |
4 | RNA PHAGE | authKW | 248487 | 1% | 92% | 11 |
5 | COCAINE HYDROLASE | authKW | 224030 | 1% | 91% | 10 |
6 | RNA BACTERIOPHAGES | authKW | 205360 | 1% | 83% | 10 |
7 | BACTERIOPHAGE Q BETA | authKW | 149084 | 1% | 55% | 11 |
8 | COCAINE VACCINE | authKW | 147861 | 0% | 100% | 6 |
9 | LEVIVIRIDAE | authKW | 126736 | 0% | 86% | 6 |
10 | POLONIES | authKW | 126736 | 0% | 86% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1679 | 33% | 0% | 407 |
2 | Pharmacology & Pharmacy | 978 | 18% | 0% | 228 |
3 | Immunology | 537 | 12% | 0% | 144 |
4 | Virology | 347 | 5% | 0% | 56 |
5 | Substance Abuse | 300 | 3% | 0% | 31 |
6 | Medicine, Research & Experimental | 293 | 7% | 0% | 85 |
7 | Biophysics | 169 | 5% | 0% | 66 |
8 | Biotechnology & Applied Microbiology | 161 | 6% | 0% | 78 |
9 | Psychiatry | 151 | 5% | 0% | 63 |
10 | Biochemical Research Methods | 94 | 4% | 0% | 48 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL MODELING BIOPHARMACEUT | 70396 | 1% | 29% | 10 |
2 | WIRM | 56309 | 1% | 19% | 12 |
3 | NETHERLANDS ELE ON NANOSCOPY | 49287 | 0% | 100% | 2 |
4 | ADJUVANT ANTIGEN | 48291 | 1% | 28% | 7 |
5 | EA4222 | 44713 | 1% | 26% | 7 |
6 | OTTAWA S | 44356 | 0% | 60% | 3 |
7 | WORM MED WIRM | 44000 | 0% | 36% | 5 |
8 | WORM MED | 43256 | 1% | 15% | 12 |
9 | IMMUNOASSAY MOL DIAG | 32857 | 0% | 67% | 2 |
10 | COMM NEUROBIOL ADDICT DISORDERS | 31557 | 2% | 6% | 20 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF MOLECULAR BIOLOGY | 5709 | 6% | 0% | 74 |
2 | BERICHTE DER BUNSEN-GESELLSCHAFT-PHYSICAL CHEMISTRY CHEMICAL PHYSICS | 1721 | 1% | 0% | 18 |
3 | INTERNATIONAL IMMUNOPHARMACOLOGY | 1620 | 1% | 0% | 17 |
4 | VACCINE | 1524 | 3% | 0% | 34 |
5 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1462 | 3% | 0% | 36 |
6 | CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS | 993 | 0% | 1% | 6 |
7 | NUCLEIC ACIDS RESEARCH | 985 | 3% | 0% | 41 |
8 | BIOPHYSICAL CHEMISTRY | 960 | 1% | 0% | 13 |
9 | EXPERT REVIEW OF VACCINES | 958 | 1% | 1% | 7 |
10 | PUBLIC HEALTH ETHICS | 934 | 0% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | Q BETA REPLICASE | 452993 | 2% | 74% | 25 | Search Q+BETA+REPLICASE | Search Q+BETA+REPLICASE |
2 | NICOTINE VACCINE | 277647 | 1% | 87% | 13 | Search NICOTINE+VACCINE | Search NICOTINE+VACCINE |
3 | IMMUNOPHARMACOTHERAPY | 248487 | 1% | 92% | 11 | Search IMMUNOPHARMACOTHERAPY | Search IMMUNOPHARMACOTHERAPY |
4 | RNA PHAGE | 248487 | 1% | 92% | 11 | Search RNA+PHAGE | Search RNA+PHAGE |
5 | COCAINE HYDROLASE | 224030 | 1% | 91% | 10 | Search COCAINE+HYDROLASE | Search COCAINE+HYDROLASE |
6 | RNA BACTERIOPHAGES | 205360 | 1% | 83% | 10 | Search RNA+BACTERIOPHAGES | Search RNA+BACTERIOPHAGES |
7 | BACTERIOPHAGE Q BETA | 149084 | 1% | 55% | 11 | Search BACTERIOPHAGE+Q+BETA | Search BACTERIOPHAGE+Q+BETA |
8 | COCAINE VACCINE | 147861 | 0% | 100% | 6 | Search COCAINE+VACCINE | Search COCAINE+VACCINE |
9 | LEVIVIRIDAE | 126736 | 0% | 86% | 6 | Search LEVIVIRIDAE | Search LEVIVIRIDAE |
10 | POLONIES | 126736 | 0% | 86% | 6 | Search POLONIES | Search POLONIES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PRAVETONI, M , (2016) BIOLOGICS TO TREAT SUBSTANCE USE DISORDERS: CURRENT STATUS AND NEW DIRECTIONS.HUMAN VACCINES & IMMUNOTHERAPEUTICS. VOL. 12. ISSUE 12. P. 3005 -3019 | 109 | 64% | 0 |
2 | SALAZAR-JUAREZ, A , MENDEZ, SB , JURADO, N , ANTON, B , (2016) ENZYMES INVOLVED IN COCAINE METABOLISM: A NEW PHARMACOLOGICAL APPROACH TO TREATING COCAINE OVERDOSE INTOXICATION.SALUD MENTAL. VOL. 39. ISSUE 6. P. 311 -320 | 88 | 77% | 0 |
3 | PUMPENS, P , RENHOFA, R , DISHLERS, A , KOZLOVSKA, T , OSE, V , PUSHKO, P , TARS, K , GRENS, E , BACHMANN, MF , (2016) THE TRUE STORY AND ADVANTAGES OF RNA PHAGE CAPSIDS AS NANOTOOLS.INTERVIROLOGY. VOL. 59. ISSUE 2. P. 74 -110 | 136 | 44% | 0 |
4 | ZALEWSKA-KASZUBSKA, J , (2015) IS IMMUNOTHERAPY AN OPPORTUNITY FOR EFFECTIVE TREATMENT OF DRUG ADDICTION?.VACCINE. VOL. 33. ISSUE 48. P. 6545 -6551 | 64 | 84% | 2 |
5 | OHIA-NWOKO, O , KOSTEN, TA , HAILE, CN , (2016) ANIMAL MODELS AND THE DEVELOPMENT OF VACCINES TO TREAT SUBSTANCE USE DISORDERS.ANIMAL MODELS FOR MEDICATIONS SCREENING TO TREAT ADDICTION. VOL. 126. ISSUE . P. 263 -291 | 72 | 64% | 1 |
6 | SCHINDLER, CW , GOLDBERG, SR , (2012) ACCELERATING COCAINE METABOLISM AS AN APPROACH TO THE TREATMENT OF COCAINE ABUSE AND TOXICITY.FUTURE MEDICINAL CHEMISTRY. VOL. 4. ISSUE 2. P. 163-175 | 62 | 78% | 8 |
7 | GORELICK, DA , (2012) PHARMACOKINETIC STRATEGIES FOR TREATMENT OF DRUG OVERDOSE AND ADDICTION.FUTURE MEDICINAL CHEMISTRY. VOL. 4. ISSUE 2. P. 227-243 | 49 | 75% | 14 |
8 | SALAZAR-JUAREZ, A , MENDEZ, SB , JURADO, N , MUNGUIA, A , ANTON, B , (2015) ACTIVE IMMUNOPROTECTION TO COCAINE.SALUD MENTAL. VOL. 38. ISSUE 6. P. 441 -447 | 42 | 88% | 0 |
9 | MILLER, ML , MORENO, AY , AARDE, SM , CREEHAN, KM , VANDEWATER, SA , VAILLANCOURT, BD , WRIGHT, MJ , JANDA, KD , TAFFE, MA , (2013) A METHAMPHETAMINE VACCINE ATTENUATES METHAMPHETAMINE-INDUCED DISRUPTIONS IN THERMOREGULATION AND ACTIVITY IN RATS.BIOLOGICAL PSYCHIATRY. VOL. 73. ISSUE 8. P. 721-728 | 40 | 78% | 17 |
10 | FU, Y , LI, JM , (2016) A NOVEL DELIVERY PLATFORM BASED ON BACTERIOPHAGE MS2 VIRUS-LIKE PARTICLES.VIRUS RESEARCH. VOL. 211. ISSUE . P. 9 -16 | 45 | 50% | 2 |
Classes with closest relation at Level 2 |